Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
schizophrenia
Podcast
What were the biggest clinical trial flops of 2024?
This week on "The Top Line," we dive into the biggest clinical trial failures of 2024 and discuss what the industry can learn from these setbacks.
Andrea Park
,
James Waldron
,
Gabrielle Masson
Feb 21, 2025 9:00am
2024's top 10 clinical trial flops
Feb 18, 2025 3:00am
Boehringer's schizophrenia drug fails trio of phase 3 trials
Jan 16, 2025 11:58am
Phase 2 schizophrenia fails will cost AbbVie about $3.5B
Jan 10, 2025 11:06am
LB Pharma's twist on old Sanofi drug passes schizophrenia test
Jan 8, 2025 7:00am
Reviva’s drug reduces symptoms in year-long schizophrenia study
Dec 16, 2024 10:29am